ACT On SCNT-Based Therapies
(From the Life Extension Foundation News). Advanced Cell Technology (ACT) is back to work on therapeutic cloning (also known as somatic cell nuclear transfer, or SCNT) to repair age-damaged immune systems: "These cloned stem cells appear to have a powerful regenerative capacity ... The ability to regenerate an aged or defective immune system without the need for drugs, tissue matching, or the risk of graft-versus-host disease would have important implications for medicine. We hope to use this technology in the future to treat patients with diverse diseases such as marrow failure disorders, various genetic diseases and malignancies, as well as debilitating autoimmune diseases, including MS, arthritis, diabetes, and lupus."